UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?

Pharmacotherapy, 2013-02, Vol.33 (2), p.210-222

2013

Link zum Volltext

Verfügbarkeit prüfen

CYP3A4-mediated pharmacokinetic interactions in cancer therapy

Current drug metabolism, 2014-01, Vol.15 (8), p.808

2014

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

Cancer discovery, 2019-03, Vol.9 (3), p.384-395

2019

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect

CPT: pharmacometrics and systems pharmacology, 2024-03, Vol.13 (3), p.476-493

2024

Link zum Volltext

Verfügbarkeit prüfen

Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi)

Drug metabolism and disposition, 2013-07, Vol.41 (7), p.1457

2013

Link zum Volltext

Verfügbarkeit prüfen

Pediatric model‐based dose optimization using a pooled exposure–response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma

CPT: pharmacometrics and systems pharmacology, 2024-01, Vol.13 (1), p.168-179

2024

Link zum Volltext

Verfügbarkeit prüfen

HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo

PloS one, 2015-02, Vol.10 (2), p.e0116886-e0116886

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics

Drug development and industrial pharmacy, 2014-07, Vol.40 (7), p.910-918

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between Common CYP1A2 Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers

Basic & clinical pharmacology & toxicology, 2013-04, Vol.112 (4), p.257-263

2013

Link zum Volltext

Verfügbarkeit prüfen

Accurate determination of the anticancer prodrug simmitecan and its active metabolite chimmitecan in various plasma samples based on immediate deactivation of blood carboxylesterases

Journal of Chromatography A, 2011-09, Vol.1218 (38), p.6646-6653

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT1 receptor antagonist

European journal of pharmacology, 2008-07, Vol.589 (1-3), p.220-224

2008

Link zum Volltext

Verfügbarkeit prüfen

Exposure-Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma

Clinical cancer research, 2022-04, Vol.28 (8), p.1603-1613

2022

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous determination of 6β-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-11, Vol.826 (1), p.238-243

2005

Link zum Volltext

Verfügbarkeit prüfen

Oral bioavailability and brain penetration of (−)‐stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in rats

British journal of pharmacology, 2009-11, Vol.158 (5), p.1302-1312

2009

Link zum Volltext

Verfügbarkeit prüfen

Sequential hydrolysis of dabigatran etexilate to its active metabolite by human carboxylesterase 1 and 2 (1064.6)

The FASEB journal, 2014-04, Vol.28 (S1), p.n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of alcohol on clopidogrel metabolism: Identification of a new alcohol‐dependent metabolic pathway (1141.14)

The FASEB journal, 2014-04, Vol.28 (S1), p.n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors

Future oncology (London, England), 2023-01, Vol.19 (2), p.123-135

2023

Link zum Volltext

Verfügbarkeit prüfen

Oral bioavailability and brain penetration of (−)‐stepholidine, a tetrahydroprotoberberine agonist at dopamine D 1 and antagonist at D 2 receptors, in rats

British journal of pharmacology, 2009-11, Vol.158 (5), p.1302-1312

2009

Link zum Volltext

Verfügbarkeit prüfen

L-1416, a novel MDR reversing agent with possible reduced calcium antagonism

Pharmacological reports, 2014-12, Vol.66 (6), p.1140-1147

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between Common CYP 1 A 2 Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers

Basic & clinical pharmacology & toxicology, 2013-04, Vol.112 (4), p.257-263

2013

Link zum Volltext

Verfügbarkeit prüfen

Association between Common CYPIA2 Polymorphisms and Theophylline Metabolism in Non-smoking Healthy Volunteers

Basic & clinical pharmacology & toxicology, 2013, Vol.112 (4), p.257-263

2013

Link zum Volltext

Verfügbarkeit prüfen

Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist

European journal of pharmacology, 2008-07, Vol.589 (1-3), p.220-224

2008

Link zum Volltext

Verfügbarkeit prüfen

Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT 1 receptor antagonist

European journal of pharmacology, 2008, Vol.589 (1), p.220-224

2008

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-11, Vol.826 (1-2), p.238-243

2005

Link zum Volltext

Verfügbarkeit prüfen

Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D(1) and antagonist at D(2) receptors, in rats

British journal of pharmacology, 2009-11, Vol.158 (5), p.1302

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(91)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(33)
Technology
(26)
Humans
(24)
Engineering
(18)
Male
(17)
Physical Sciences
(16)
Animals
(14)
Science & Technology - Other Topics
(14)
Pharmacology & Pharmacy
(12)
Chemistry
(11)
Rats
(9)
Adult
(8)
Analysis
(8)
Engineering, Electrical & Electronic
(8)
Female
(8)
Multidisciplinary Sciences
(8)
Rats, Sprague-Dawley
(8)
Biological And Medical Sciences
(7)
Computer Science
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?

CYP3A4-mediated pharmacokinetic interactions in cancer therapy

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect

Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi)

Pediatric model‐based dose optimization using a pooled exposure–response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma

HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics

Association between Common CYP1A2 Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers

Accurate determination of the anticancer prodrug simmitecan and its active metabolite chimmitecan in various plasma samples based on immediate deactivation of blood carboxylesterases

Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT1 receptor antagonist

Exposure-Response Analysis to Support Nivolumab Once Every 4 Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma

Simultaneous determination of 6β-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity

Oral bioavailability and brain penetration of (−)‐stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in rats

Sequential hydrolysis of dabigatran etexilate to its active metabolite by human carboxylesterase 1 and 2 (1064.6)

Effect of alcohol on clopidogrel metabolism: Identification of a new alcohol‐dependent metabolic pathway (1141.14)

TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors

Oral bioavailability and brain penetration of (−)‐stepholidine, a tetrahydroprotoberberine agonist at dopamine D 1 and antagonist at D 2 receptors, in rats

L-1416, a novel MDR reversing agent with possible reduced calcium antagonism

Association between Common CYP 1 A 2 Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers

Association between Common CYPIA2 Polymorphisms and Theophylline Metabolism in Non-smoking Healthy Volunteers

Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist

Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT 1 receptor antagonist

Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity

Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D(1) and antagonist at D(2) receptors, in rats

Suchergebnisse filtern